The effect of herbal medicine Toki-shakuyaku-san on blood pressure in an Nω-nitro-L-arginine methyl ester-induced pre-eclampsia rat model during pregnancy and the postpartum period

Journal of Pharmacological Sciences

Volumn 98, Issue 3, 2005, Pages 255-262

  Takei, Hisato ^a   Yamamoto, Masahiro ^a   Kase, Yoshio ^a   Takeda, Shuichi ^a  

^a TSUMURA AND CO   (Japan)

Author keywords

Hypertension; Postpartum period; Pre eclampsia; Progesterone; Toki shakuyaku san

Indexed keywords

ANTIGESTAGEN; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; MIFEPRISTONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROGESTERONE; SEX HORMONE; TOKISHAKUYAKU SAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HERBAL MEDICINE; MALE; MATERNAL HYPERTENSION; NONHUMAN; PREECLAMPSIA; PUERPERIUM; RAT; STEROID BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 24744471431     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ04043X     Document Type: Article

References (38)

1. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol. 1995;22:781-791.
2. Sibai BM, Schneider JM, Morrison JC, Lipshitz J, Anderson GD, Shier RW, et al. The late postpartum eclampsia controversy. Obstet Gynecol. 1980;55:74-78.
3. Long PA, Oats JN, Beischer NA. Labour-onset pre-eclampsia. Aust N Z J Obstet Gynecol. 1981;21:16-19.
4. Miles JF, Martin JN, Blake PG, Perry KG, Martin RW, Meeks GR. Postpartum eclampsia: a recurring perinatal dilemma. Obstet Gynecol. 1990;76:328-331.
5. Koyama T. Role of Kampo (herbal) medicine for management in postmenopausal women in Japan. J Jpn Menopause Soc. 1993;1:75-79.
6. Kano T, Ito C, Kasamatsu H, Miyawaki Y. Clinical study of prognosis of 200 deliveries after Kampo-treatment for ovarian dysfunctional infertilities and tocolysis. Jpn J Fertil Steril. 1991;36:612-620.
7. Noguchi K. Study on gestosis cases for the past decade - Effect of Tokishakuyakusan and holding of mothers' class. Jap J Prim Care. 1985;8:131-133. (text in Japanese with English abstract)
8. Irahara M, Yasui T, Tezuka M, Ushigoe K, Yamano S, Kamada M, et al. Evidence that Toki-shakuyaku-san and its ingredients enhance the secretion of a cytokine-induced neutrophil chemoattractant (CINC/gro) in the ovulatory process. Methods Find Exp Clin Pharmacol. 2000;22:725-730.
9. Usuki S. Effects of Tokishakuyakusan and its components on rat corpus luteum function in vitro. Am J Chin Med. 1988;16:11-19.
10. Takei H, Nakai Y, Hattori N, Yamamoto M, Kurauchi K, Sasaki H, et al. The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclmpsia rats induced by Nω-nitro-L-arginine methyl ester. Phytomedicine. 2004;11:43-50.
11. Taya K, Greenwald GS. In vivo and in vitro ovarian steroidogenesis in the pregnant rat. Biol Reprod. 1981;25:683-691.
12. Taya K, Greenwald GS. Peripheral blood and ovarian levels of sex steroids in the lactating rat. Endocrinol Jpn. 1982;29:453-459.
13. Kawano T, Okamura H, Tajima C, Fukuma K, Katabuchi H. Effect of RU 486 on luteal function in the early pregnant rat. J Reprod Fert. 1988;83:279-285.
14. Raynaud JP, Ojasoo T. La promégestone, un nouveau progestatif. J Gynecol Obstet Biol Repr (Paris). 1983;12:679-710.
15. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Preeclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod. 1995;10:2723-2730.
16. Liao QP, Buhimschi IA, Saade G, Chwalisz K, Garfield RE. Regulation of vascular adaptation during pregnancy and postpartum: effects of nitric oxide inhibition and steroid hormones. Hum Reprod. 1996;11:2777-2784.
17. Usuki S. Effects of Tokishakuyakusan and Keishibukuryogan on steroidogenesis by rat preovulatory follicles in vivo. Am J Chin Med. 1990;18:149-156.
18. Kalimi M. Receptor-mediated antiprogestin action of RU 486. In: Agarwal MK, editor. Receptor Mediated Antisteroid Action. New York: de Gruyter; 1987. p. 121-137.
19. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, et al. Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol. 1994;171:1243-1250.
20. Tippins JR. CGRP: A novel neuropeptide from the calcitonin gene is the most potent vasodilator known. J Hypertens. 1986;4:S102-S105.
21. Wimalawansa SJ, Yallampalli C. Pre-eclamptic toxemia: potential new therapy based on animal studies. Ceylon Med J. 1998;43:138-146.
22. Edwards DL, Arora CP, Bui DT, Castro LC. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Am J Obstet Gynecol. 1996;175:484-488.
23. Olson GL, Saade GR, Buhimschi I, Chwalisz K, Garfield RE. The effect of an endothelin antagonist on blood pressure in a rat model of pre-eclampsia. Am J Obstet Gynecol. 1999;181:638-641.
24. G-nitro-L- arginine methyl ester-induced hypertension. Am J Obstet Gynecol. 1997;176:894-900.
25. Rosenfeld MG, Mernod J, Amara SG, Swanson LW, Sawchenko PE, Rivier J, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature. 1983;304:129-135.
26. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev. 1996;17:533-585.
27. Ueda Y, Komatsu M, Hiramatsu M. Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain. Neurochem Res. 1996;21:909-914.
28. Roberts JM, Pearson G, Culter J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41:437-445.
29. Ueda J, Ohya E, Udagawa K, Hara A, Fukui M, Yamagishi H, et al. Effect of kampo medicines on the peripheral blood flow rate of betamethason-induced oketsu syndrome mice by laser Doppler flow meter. Yakugaku Zasshi. 2004;124:365-369. (text in Japanese with English abstract)
30. Sugawara K, Ohkubo T, Nagasaki T, Hayakari M. Angiotensinconverting enzyme inhibitory activity of kampo medicines. J Drug Interac Res. 1996;20:29-37.
31. Tagaya E, Tamaoki J, Kawatani K, Taira M, Nagai A. Inhibition of airway smooth muscle tone by Chinese herbal medicines. Eur Respir J. 2000;6:1123-1128.
32. Itoh T, Michijiri S, Murai S, Saito H, Nakamura K, Itsukaichi O, et al. Regulatory effect of Danggui-shaoyao-san on central cholinergic nervous system dysfunction in mice. Am J Chin Med. 1996;24:205-217.
33. Komatsu M, Ueda Y, Hiramatsu M. Different changes in concentrations of monoamines and their metabolites and amino acids in various brain regions by the herbal medicine/Toki-Shakuyaku-San between female and male senescenceaccelerated mice (SAMP8). Neurochem Res. 1999;24:825-831.
34. Toriizuka K, Hou P-H, Yabe T, Iijima K, Hanawa T, Cyong J-C. Effect of Kampo medicine, Toki-shakuyaku-san (Tang-Kuei-Shao-Yao-San), on choline acetyltransferase activity and norepinephrine contents in brain regions, and mitogenic activity of splenic lymphocytes in ovariectomized mice. J Ethnopharmacol. 2000;71:133-143.
35. Song Q-H, Toriizuka K, Jin G-B, Yabe T, Cyong J-C. Long term effects of Toki-shakuyaku-san on brain dopamine and nerve growth factor in olfactory-bulb-lesioned mice. Jpn J Pharmacol. 2001;86:183-188.
36. Damron DP, Bernstein IM, Shapiro RE, Schonberg A. Uterine blood flow response to alpha-adrenergic blockade in nulligravid women of reproductive age. J Soc Gynecol Investig. 2004;11:388-392.
37. Kaaja RJ, Leinonen A, Moore P, Yandle T, Frampton CM, Nicholls MG. Effect of changes in body posture on vasoactive hormones in pre-eclamptic women. J Hum Hypertens. 2004;18:789-794.
38. Yousif MH, Chandrasekhar B, Kadavil EA, Oriowo MA. Noradrenaline-induced vasoconstriction in the uterine vascular bed of pregnant rats chronically treated with L-NAME: Role of prostanoids. J Cardiovasc Pharmacol. 2003;42:428-435.